Emerging therapeutic targets in metastatic progression: A focus on breast cancer

Area of Science:

• Oncology
• Cancer Metastasis Research

Background:

• Metastasis is the primary cause of death in breast cancer patients.
• Current therapies for metastatic breast cancer are insufficient, posing a major challenge in reducing late-stage mortality.

Purpose of the Study:

• To review emerging therapeutic targets for breast cancer metastasis.
• To discuss strategies for developing precision treatments by targeting both tumor-intrinsic properties and the tumor microenvironment.

Main Methods:

• Genomic analysis of breast cancer.
• Molecular dissection of tumor-stromal interactions.
• Review of current literature on therapeutic targets and combination strategies.

Main Results:

• Genomic analysis and tumor-stromal cross-talk have identified promising targets for metastatic breast cancer.
• Rational combinations of therapies targeting tumor-intrinsic pathways and microenvironmental components offer a promising strategy.

Conclusions:

• Emerging therapeutic targets encompass both tumor-intrinsic pathways and host tissue components, including the immune system.
• Developing precision treatments with improved specificity and reduced toxicity is key to combating breast cancer metastasis.